...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Feb. 06, 2019 FMV ZENE!

Tada - I agree with you. I have read the process and agree with what you are saying. I am just questioning whether or not Zenith has done that. I have some doubts and they have stated to only use their number for one purpose. That is where I get the idea of a value that CRA will accept. 

I am not saying it can't be done and good for anyone that does it and it works. I have just tried to make sure everyone reading this is aware of everything before they do it. Everyone make sure you are comfortable with it before doing it.

Share
New Message
Please login to post a reply